News-Medical.Net February 28, 2025
Atlantia Clinical Trials

A global elderly and aging population has significant impacts, not only in terms of individual health risk but in terms of societal pressures and issues. The Chief Commercial Officer at Atlantia Clinical Trials, Barry Skillington, and long-term Atlantia clinical trial expert Emily Goodbody explore how an aging population is analyzed, looking into the future of how the food and nutraceutical market could used to tackle the rise of healthy aging.

With a suggested three-pronged model of education, healthy-aging marketing, and building trust in the product, Barry and Emily consider that this space is freeing up for the future of clinical trials and the wider world.

Please could you introduce yourself and outline your role at Atlantia Clinical Trials?

BS: My...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Clinical Trials, Interview / Q&A, Patient / Consumer, Provider, Trends
Related Articles:
Inclusive Communication the Key to Better Eye Care
To the Pandemic Czar: Are We Prepared to Talk About Bird Flu?
New dietary guidelines should prioritize plants and healthy beverages
Republicans Once Wanted Government Out of Healthcare. Trump Voters Are Different.
Measles outbreak continues to spike with nearly 150 reported cases

Share This Article